Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J H Porter

Showing results (151-160 of 232) with videos related to

Pageof 24
Sort By:
International Journal of Pharmaceutics|January 24, 2021
Intestinal delivery in a long-chain fatty acid formulation enables lymphatic transport and systemic exposure of orlistatGiven Lee, Sifei Han, Zijun Lu, et al.
Pharmacological Reviews|February 7, 2013
Strategies to address low drug solubility in discovery and developmentHywel D Williams, Natalie L Trevaskis, Susan A Charman, et al.
Biomacromolecules|July 22, 2017
An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous AdministrationLinda J Chan, Orlagh M Feeney, Nathania J Leong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2013
PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastasesLisa M Kaminskas, David B Ascher, Victoria M McLeod, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 29, 2013
Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluationTri-Hung Nguyen, Angel Tan, Leilani Santos, et al.
Molecular Pharmaceutics|August 16, 2018
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide LinkerDharmini Mehta, Nathania Leong, Victoria M McLeod, et al.
Frontiers in Pharmacology|May 2, 2022
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic TransportTim Quach, Luojuan Hu, Sifei Han, et al.
ACS Applied Materials & Interfaces|July 21, 2021
Quantitatively Tracking Bio-Nano Interactions of Metal-Phenolic Nanocapsules by Mass CytometryShiyao Li, Yi Ju, Jiajing Zhou, et al.
Angewandte Chemie (International Ed. in English)|August 3, 2016
Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral BioavailabilityLuojuan Hu, Tim Quach, Sifei Han, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2019
Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulationEnyuan Cao, Anna Lindgren, Sofia Martinsson, et al.
Pageof 24

Showing results (151-160 of 232) with videos related to

Sort By:
Pageof 24
International Journal of Pharmaceutics|January 24, 2021
Intestinal delivery in a long-chain fatty acid formulation enables lymphatic transport and systemic exposure of orlistatGiven Lee, Sifei Han, Zijun Lu, et al.
Pharmacological Reviews|February 7, 2013
Strategies to address low drug solubility in discovery and developmentHywel D Williams, Natalie L Trevaskis, Susan A Charman, et al.
Biomacromolecules|July 22, 2017
An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous AdministrationLinda J Chan, Orlagh M Feeney, Nathania J Leong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2013
PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastasesLisa M Kaminskas, David B Ascher, Victoria M McLeod, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 29, 2013
Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluationTri-Hung Nguyen, Angel Tan, Leilani Santos, et al.
Molecular Pharmaceutics|August 16, 2018
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide LinkerDharmini Mehta, Nathania Leong, Victoria M McLeod, et al.
Frontiers in Pharmacology|May 2, 2022
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic TransportTim Quach, Luojuan Hu, Sifei Han, et al.
ACS Applied Materials & Interfaces|July 21, 2021
Quantitatively Tracking Bio-Nano Interactions of Metal-Phenolic Nanocapsules by Mass CytometryShiyao Li, Yi Ju, Jiajing Zhou, et al.
Angewandte Chemie (International Ed. in English)|August 3, 2016
Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral BioavailabilityLuojuan Hu, Tim Quach, Sifei Han, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2019
Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulationEnyuan Cao, Anna Lindgren, Sofia Martinsson, et al.
Pageof 24